Overview
iXCells Biotechnologies is a U.S.-based cell technology company founded in 2014, focused on developing advanced cellular models and enabling technologies for preclinical drug discovery. The company specializes in induced pluripotent stem cell (iPSC) technology, offering a wide range of iPSC-derived cell types, primary cells, and disease-specific cellular models for research applications. iXCells provides both products and services, including custom iPSC generation, genome editing, cell differentiation, and functional bioassay development, supporting academic, biotech, and pharmaceutical research. A key strength is its ability to generate predictive human disease models, enabling researchers to better understand disease mechanisms and accelerate drug discovery workflows.
Key techniques
iXCells products and services support advanced cell biology, stem cell, and gene engineering workflows
Product lines
iXCells offers a comprehensive portfolio of cellular models and services designed for drug discovery and disease research
Cells ›
Capabilities
iXCells integrates stem cell biology, gene engineering, and assay development technologies to create advanced cellular models for biomedical research
QC & documentation
iXCells provides detailed technical documentation and validation data to ensure reproducibility in research workflows
Lead time & shipping
Delivery timelines vary depending on product type and customization requirements